Publication | Open Access

Heterologous prime-boost vaccination with a non-replicative vaccinia recombinant vector expressing LACK confers protection against canine visceral leishmaniasis with a predominant Th1-specific immune response

VaccinationCanine Visceral LeishmaniasisVaccine DevelopmentMedicineVaccine TargetPathogenesisImmunologyLack Confers ProtectionImmunotherapeuticsHeterologous Prime-boost VaccinationVaccine DesignPrecision VaccinologyVisceral LeishmaniasisParasitology